Daiwa Securities Group
JANX icon

Daiwa Securities Group’s Janux Therapeutics JANX Stock Holding History

Daiwa Securities Group’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-187
Closed -$3K – 1313
2025
Q4 		$3K Hold
187
– – ﹤0.01% 1276
2025
Q3 		$5K Hold
187
– – ﹤0.01% 1205
2025
Q2 		$4K Hold
187
– – ﹤0.01% 1173
2025
Q1 		$5K Hold
187
– – ﹤0.01% 1133
2024
Q4 		$10K Hold
187
– – ﹤0.01% 1120
2024
Q3 		$8K Hold
187
– – ﹤0.01% 1143
2024
Q2 		$8K Hold
187
– – ﹤0.01% 1174
2024
Q1 		$7K Buy
+187
New +$4.07K ﹤0.01% 1186
2022
Q4 		– Sell
-121
Closed -$2K – 1343
2022
Q3 		$2K Hold
121
– – ﹤0.01% 1234
2022
Q2 		$1K Hold
121
– – ﹤0.01% 1293
2022
Q1 		$2K Hold
121
– – ﹤0.01% 1256
2021
Q4 		$2K Buy
+121
New +$2.54K ﹤0.01% 1285

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Daiwa Securities Group's JANX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Janux Therapeutics (JANX) in Q1 2026, closing a stake of 187 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in JANX in Q4 2021 and held it in 12 quarters. The position peaked at $10K in Q4 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Janux Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 187 Janux Therapeutics shares in Q1 2026, an estimated $3K.
  • Daiwa Securities Group first reported a position in Janux Therapeutics in Q4 2021 and held it in 12 quarters.
  • Daiwa Securities Group's Janux Therapeutics position peaked at $10K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.